Young T. Kwon

Dr. Kwon has been a director of ADMA since October 2021. He is Chief Financial and Operating Officer at Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies in neurodegeneration and oncology.